iBio (IBIO) Receivables - Other (2014 - 2024)
iBio's (IBIO) quarterly Receivables - Other came in at $14.1 million in Q1 2024, up 176.55% year-on-year from $5.1 million in Q2 2023, and up 176.55% on a QoQ basis from $5.1 million in Q1 2023.
iBio (IBIO) Receivables - Other (2014 - 2024) Analysis & Trends
iBio (IBIO) has 9 years of Receivables - Other data on file, last reported at $14.1 million in Q1 2024.
- On a quarterly basis, Receivables - Other rose 176.55% year-over-year to $14.1 million in Q1 2024; TTM through Mar 2024 was $14.1 million, a 176.55% increase from a year earlier, with the FY2023 full-year figure at $204000.0, down 96.0% from the prior year.
- Receivables - Other for Q1 2024 stood at $14.1 million, up from $5.1 million in the prior quarter.
- Over the last five years, Receivables - Other for IBIO reached as high as $14.1 million in Q1 2024 and fell as low as $1000.0 in Q1 2021.
- Historically, Receivables - Other has averaged $5.5 million across 5 years, with a median of $5.1 million in 2021.
- On a YoY basis, Receivables - Other climbed as much as 509900.0% in 2022 and fell as far as 0.0% in 2022.
- Year by year, Receivables - Other stood at $52000.0 in 2020, then soared by 9707.69% to $5.1 million in 2021, then changed by 0.0% to $5.1 million in 2022, then changed by 0.0% to $5.1 million in 2023, then jumped by 176.55% to $14.1 million in 2024.
- Per Business Quant data, the three most recent Receivables - Other figures were $14.1 million in Q1 2024, $5.1 million in Q1 2023, and $5.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 14.10 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2020 | 52,000.00 |